ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Quality Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Quality Index of 2.11x as of December 2023. Operating cash flow of CN¥192.07 Million exceeds net income of CN¥90.98 Million, indicating high earnings quality where cash backs reported profits. Explore 301201 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ChengDa Pharmaceuticals Co. Ltd. (301201) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2023)
Year-by-year earnings quality comparison for ChengDa Pharmaceuticals Co. Ltd.. For live market cap and the full company financial profile, see how much is ChengDa Pharmaceuticals Co. Ltd. worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.11x | CN¥192.07 Million | CN¥90.98 Million | ▲ +371.6% |
| 2022 | 0.45x | CN¥47.67 Million | CN¥106.48 Million | ▼ -45.9% |
| 2021 | 0.83x | CN¥83.14 Million | CN¥100.44 Million | ▼ -22.2% |
| 2020 | 1.06x | CN¥128.97 Million | CN¥121.17 Million | ▼ -14.5% |
| 2019 | 1.25x | CN¥67.52 Million | CN¥54.22 Million | — |